-- Swiss Stocks Decline as SMI Retreats for a Second Day
-- B y   C o r i n n e   G r e t l e r
-- 2013-04-15T08:02:11Z
-- http://www.bloomberg.com/news/2013-04-15/swiss-stocks-decline-as-smi-retreats-for-a-second-day.html
Swiss stocks  declined, after
posting the biggest weekly gain in a month, as  Nestle SA (NESN)  traded
without the right to its latest dividend and investors awaited a
report on manufacturing in the New York Area.  Kuehne & Nagel (KNIN)  International AG advanced after the world’s
biggest sea-freight forwarder said first-quarter profit almost
doubled.  Roche Holding AG (ROG) , the world’s biggest maker of cancer
drugs, climbed 1.3 percent, while Novartis added 1.1 percent.  The SMI fell 0.3 percent to 7,734.41 at 10 a.m. in Zurich.
The measure has still rallied 13 percent this year as U.S.
lawmakers agreed on a compromise budget and data on housing and
jobs fueled optimism the world’s biggest economy is recovering.
The broader Swiss Performance Index climbed 0.3 percent today.  In the U.S., a report at 8:30 a.m. local time may show that
 manufacturing  in the New York region expanded for a third month
in April. The Federal Reserve Bank of New York’s general
economic index slowed to 7 this month from 9.24 in March,
economists forecast in a Bloomberg News survey. Readings greater
than zero mean that activity increased.  In  China , gross domestic product rose 7.7 percent in the
first quarter, the National Bureau of Statistics said in
Beijing. That compared with the 8 percent  median forecast  by
analysts in a Bloomberg News survey and 7.9 percent in the
fourth quarter. The country’s industrial production increased in
March at a slower pace than economists’ had estimated, while
retail-sales growth matched forecasts.  Nestle Ex-Dividend  Nestle, which accounts for almost 23 percent of weight in
the  SMI (SMI) , shaved almost 55 points off the gauge as the shares
traded without the right to their latest dividend. Adjusting for
the lost dividend, the shares rose 0.5 percent to 65.70 francs
on a comparable basis.  Kuehne & Nagel jumped 3.7 percent to 109.50 francs after
saying as profit almost doubled as air freight and contract
logistics units benefited from measures to raise profitability
at the company.  First-quarter net income rose to 132 million francs ($142
million) from 67 million francs in the first three months last
year. Revenue rose 5.4 percent to 5.09 billion francs.  Roche climbed 1.3 percent to 227.90 francs. The world’s
largest maker of cancer drugs entered into a collaboration with
Ascletis Inc. to develop and commercialize Roche’s
investigational drug danoprevir in China for the treatment of
Hepatitis C Virus.  Novartis rose 1.1 percent to 68.55 francs. A gauge of
European health-care companies posted the second-best
performance of the 19 industry groups in the Stoxx Europe 600
Index.  Burkhalter Holding AG (BRKN)  rose 4.3 percent to 330 francs after
Switzerland’s biggest electrical installations company said
full-year earnings per share amounted to 22.63 francs. the
company also expressed optimism over its prospects for 2013.  The volume of shares changing hands in companies on the SMI
today was 1.9 percent lower than the average of the past 30
days, according to data compiled by Bloomberg.  To contact the reporter on this story:
Corinne Gretler in Zurich at 
 cgretler1@bloomberg.net   To contact the editor responsible for this story:
Andrew Rummer at 
 arummer@bloomberg.net  